Clinical Trials Logo

Total Joint Arthroplasty clinical trials

View clinical trials related to Total Joint Arthroplasty.

Filter by:
  • None
  • Page 1

NCT ID: NCT01909375 Enrolling by invitation - Clinical trials for Total Joint Arthroplasty

American Joint Replacement Registry

AJRR
Start date: August 2011
Phase: N/A
Study type: Observational [Patient Registry]

The American Joint Replacement Registry is a not-for-profit 501(c)(3) organization for data collection and quality improvement initiatives for total hip and knee replacements. The AJRR is a collaborative effort supported by the American Academy of Orthopaedic Surgeons (AAOS), the American Association of Hip and Knee Surgeons (AAHKS), The Hip Society, The Knee Society, hospitals, health insurers, medical device manufacturers, and contributions from individual orthopaedic surgeons.

NCT ID: NCT01636414 Active, not recruiting - Clinical trials for Total Joint Arthroplasty

Reinfusion Drains vs Tranexamic Acid in Total Joint Arthroplasty

Start date: May 2012
Phase: Phase 4
Study type: Interventional

It is widely reported that a large percentage of total joint replacement patients receive allogeneic (human donor blood) blood transfusions due to perioperative blood loss with numbers ranging from 30% to 80%. The risks of allogenic blood transfusion are well documented in the literature. In addition, they are time-consuming: often lengthening hospital stay and decreasing the availability for postoperative physical therapy. Moreover, they are costly at several hundred dollars per unit, and allogeneic transfusions are linked with immunosuppression and increased postoperative infection rates and wound healing problems, which are devastating complications in this elective, joint replacement population. Several options are available for diminishing the need for allogenic blood transfusion following elective total joint replacement. These include the use of perioperative blood salvage devices (OrthoPAT) and tranexamic acid. While there is data to support the use of both OrthoPat and Tranexamic acid in primary total joint arthroplasty, there is little information comparing one versus the other in terms of efficacy and economics. The purpose of this study is to compare the safety, effectiveness and cost benefit of Hemovac drain, OrthoPAT and Tranexamic Acid to manage blood loss during total hip and total knee replacement surgery.

NCT ID: NCT01577823 Completed - Clinical trials for Total Joint Arthroplasty

Utility of Indwelling Catheter in Orthopaedic Patients Receiving Spinal Anesthesia

Start date: n/a
Phase: N/A
Study type: Interventional

A study measuring utility of indwelling bladder catheter placement in orthopaedic surgical patients receiving spinal anesthesia. Study will track clinical outcomes, patient satisfaction and cost efficacy. Absence of indwelling bladder catheter may decrease urinary tract infection (UTI) incidence, increase patient satisfaction, and decrease cost burden without increasing postoperative urinary retention (POUR) incidence.